Skip to main content


Esophageal Cancer

Featured

Guideline Updates
NCCN released an update to its clinical practice guideline for esophageal and esophageal junction cancers, adding fam-trastuzumab deruxtecan-nxki as a preferred category 2A…
Research Report
Scott Paulson, MD, and colleagues present their findings after assessing the gastric cancer treatment heterogeneity…
Guideline Updates
Modifications were similar across both guidelines, including an update on the optimal use of oxaliplatin as well as…
Research Report
Ashley E Glode, PharmD, BCOP, and colleagues conducted a pilot quality improvement project that improved chemotherapy…
Guideline Updates
Similar updates were made to the NCCN guidelines for gastric and esophageal and esophagogastric junction cancers,…
Back to Top